AC Immune (ACIU) Operating Income Growth (3y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 32.96% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -29.67% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -50.81% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 13.47% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 16.35% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -12.10% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 55.96% |
| 10 | AC Immune | 325.88 Mn | 211.53 Mn | - | 0.20% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.20% |
| Dec 31, 2025 | 2.46% |
| Sep 30, 2025 | -13.18% |
| Jun 30, 2025 | -4.33% |
| Mar 31, 2025 | -1.85% |
| Dec 31, 2024 | 4.90% |
| Sep 30, 2024 | 33.51% |
| Jun 30, 2024 | -4.19% |
| Mar 31, 2024 | -6.41% |
| Dec 31, 2023 | 42.98% |
| Sep 30, 2023 | 5.01% |
| Jun 30, 2023 | -5.21% |
| Mar 31, 2023 | -36.02% |
| Dec 31, 2022 | -0.68% |
| Sep 30, 2022 | -40.34% |
| Jun 30, 2022 | -11.85% |
| Mar 31, 2022 | -32.72% |
| Dec 31, 2021 | -19.29% |
| Sep 30, 2021 | -21.32% |
| Jun 30, 2021 | -20.36% |
| Mar 31, 2021 | -16.92% |
| Mar 31, 2020 | 1.09% |
| Dec 31, 2019 | -49.96% |
| Sep 30, 2019 | 61.39% |
| Mar 31, 2019 | 131.28% |
| Dec 31, 2018 | -31.70% |
| Sep 30, 2018 | -37.80% |